Specific anti-alpha-GAL immunocaptm phadia core laboratory testing phadia US INC:1109918 [26-008249]

Ended Purchase Order Awarded Last action

Contract number
75N98026P01418
Awardee
Awarding agency
Obligated
$22,650

Award facts

Contract value 100% obligated
$22,650.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
NIH Clinical Center National Institutes of Health, Department of Health and Human Services
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Portage, MI 49002, USA

Award details come from SAM.gov/FPDS.

About this award

The NIH Clinical Center awarded a purchase order to Phadia US Inc. on August 31, 2026, for specific anti-alpha-gal immunocap phadia core laboratory testing, with a ceiling value of $22,650.00. The order is firm fixed price with no set-aside. Performance occurs in Portage, Michigan, and the order completes September 30, 2026.

Quick answers

Who was awarded contract 75N98026P01418?

75N98026P01418 was awarded to Phadia US Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on August 31, 2026.

How much is contract 75N98026P01418 worth?

The government has obligated $22,650 on 75N98026P01418.

Which agency awarded contract 75N98026P01418?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01418, with funding from NIH Clinical Center (National Institutes of Health).

Was contract 75N98026P01418 competed?

The extent of competition for 75N98026P01418 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award